Pharmafile Logo

Three Symposia, Three Years of Fellows, One Mission: Medscape Oncology at ASCO 2026

May 14, 2026 | #ASCO26 #medscapeoncology, MedEd 

Three symposia. A third year of Fellows. AI live on the booth floor. Medscape Oncology arrives at ASCO 2026 (Booth #10099) with another ambitious oncology program.

- PMLiVE

Three Symposia at the Hilton Chicago

Online Poster 

Medscape Oncology will also be presenting outcomes research as an e-poster: The Impact of Online CME on Addressing Clinical Decision-Making for Immunotherapy in Advanced Squamous NSCLC. Authors: Michelle A. Worst, PharmD, BCOP, MBA, CHCP; Andrew Small; Amy Furedy, RN, OCN; Charu Aggarwal, MD, MPH; Sandip Patel, MD

ASCO Fellows, Year Three

For the third consecutive year, Medscape Oncology is supporting a cohort of Fellows to attend ASCO. Fellows will spend time on the booth in focus groups, go hands-on with Medscape AI and the new medical simulation solution, Clinical Readiness Studio as well as engaging with faculty across the program. 

“There is no better time to understand what oncology clinicians actually need than at the start of their specialist careers. Our Fellows tell us where the evidence gaps are, where the tools fall short, and what the next generation expects from medical education. That insight is irreplaceable, and it directly shapes what we build and what we publish. Alongside the symposia and Medscape AI, the Fellows program is central to why we show up at ASCO the way we do,” said Chris Hoffman, Chief Strategy Officer, Medscape Education. 

Medscape AI on the Booth

Medscape AI represents a new generation of clinical intelligence and research tools, drawing exclusively on a clinically validated knowledge base of expert-authored content, peer-reviewed journals, and rigorously vetted medical sources, with every response traceable to verifiable citations. Oncology is the most-queried specialty on Medscape AI, with breast cancer and lymphoma topping the list. A recent analysis of platform queries also found that diagnosis support and treatment decisions account for half of all physician queries across specialties.

 

An Indispensable Resource for Oncologists 

Medscape has been delivering oncology education, medical information, and clinical tools for over 30 years. In a recent survey of hem/onc members, 79% recognised it as an indispensable resource, 78% would recommend it to colleagues, and 75% call it their preferred CME website. The trust is there. ASCO 2026 is where we put it to work.

Find the team at Booth #10099 or reach out to Jelena Spyropoulos at jspyropoulos@medscape.net.

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

Medscape Education: Rare Diseases

It's only a few days until #RareDiseaseDay2023 on 28th February. We're taking a patient centered approach, this means understanding their journey so we can better understand how we can help to...

Together Caring for Rare Disease

Medscape Education and Medics4RareDisease are partnering on a Rare Disease Day awareness campaign. The campaign will form part of a series of short programs produced by ITN in collaboration with Genetic Alliance...

Medscape Education Wins Best Practice Award for Learner Outcomes at NAMEC

This year's winners have been announced  for the National Association of Medical Education Companies (NAMEC) awards. These awards recognize best practices-ideas or processes that can be implemented by NAMEC members to...

Medscape Education and Medics4RareDisease Uncover the Education Gaps in Their Compelling Rare Disease Day Campaign

Medscape Education and Medics4RareDisease are partnering on a Rare Disease Day awareness campaign. The campaign will form part of a series of short programs produced by ITN in collaboration with Genetic Alliance...

What Does Net Promoter Score Offer in the Evaluation of Continuing Medical Education?

Net promoter Score (NPS) has been used in many fields, such as software, clinical care, and websites, as a measure of customer satisfaction since 2003. With a single question, NPS...

DIGITAL HEALTH IN PRACTICE AND OVERCOMING DIGITAL FATIGUE

During this year’s Reuters event, Pharma 2022, WebMD CMO, Dr John Whyte discussed the ways in which digital health is growing, and the importance of educating clinicians in the right...

ESMO’s New Focus on Cancer Prevention

During ESMO 2022 in Paris, John Whyte, chief medical officer at WebMD was joined by Fabrice André, MD, PhD, Chair of the scientific committee at the European Society for Medical Oncology (ESMO),...

ESMO Patient Centricity – Highlights from Steve Clark

During #ESMO22 we brought together a panel of world-renowned experts, including WebMD CMO John Whyte, Professor Nadia Harbeck, MD, PhD, Lesley Fallowfield DBE, and Steve Clark, patient advocate and campaigns ambassador, Cancer Research UK (CRUK),...

ESMO Patient Centricity Highlights from Dr. Whyte

During #ESMO22 we brought together a panel of world-renowned experts, including WebMD CMO John Whyte, Professor Nadia Harbeck, MD, PhD, Lesley Fallowfield DBE, and Steve Clark, patient advocate and campaigns ambassador, Cancer Research UK (CRUK), volunteer...

Closing The Gaps in Patient-Centricity in Cancer Care

Highlights from the Medscape Education full panel discussion during this year's #ESMO22.